Evaluation of the carcinogenicity of carbon tetrachloride

Reevaluation of Hepatocellular Neoplasms in CD-1 Mice from a 2-year Oral Carcinogenicity Study with Permethrin

(2018) Erin M. Quist et al.   TOXICOLOGIC PATHOLOGY

HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach

(2016) H. Lebrec et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Adrenal Gland Background Findings in CD-1 (Crl:CD-1(ICR)BR) Mice from 104-week Carcinogenicity Studies

(2015) Claudio Petterino et al.   TOXICOLOGIC PATHOLOGY

Interpreting Stress Responses during Routine Toxicity Studies

(2013) Nancy E. Everds et al.   TOXICOLOGIC PATHOLOGY

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-A Swedish population-based study

(2012) Britta Krynitz et al.   INTERNATIONAL JOURNAL OF CANCER

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background

(2012) Lauren Fishbein et al.   Cancer Genetics

Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays

(2010) Samuel M. Cohen   TOXICOLOGIC PATHOLOGY

Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System

(2010) Bob Thoolen et al.   TOXICOLOGIC PATHOLOGY

Chemically induced pheochromocytomas in rats: mechanisms and relevance for human risk assessment

(2009) Helmut Greim et al.   CRITICAL REVIEWS IN TOXICOLOGY

A comparison of rat chronic progressive nephropathy with human renal disease—implications for human risk assessment

(2009) Gordon C. Hard et al.   CRITICAL REVIEWS IN TOXICOLOGY

IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans

(2008) Alan R. Boobis et al.   CRITICAL REVIEWS IN TOXICOLOGY

Evaluating genotoxicity data to identify a mode of action and its application in estimating cancer risk at low doses: A case study involving carbon tetrachloride

(2008) David A. Eastmond   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS